Francisco Hermida‐Prado

SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4

Konstantinos Tzelepis, Étienne De Braekeleer, Demetrios Aspris et al. · Nature Communications · 2018 · 88 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

Darío García‐Carracedo, M. Ángeles Villaronga, Saúl Álvarez–Teijeiro et al. · Oncotarget · 2016 · 77 citations · Full text

Medicine, Cancer Biology, Oncology +17

YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib

Irati Garmendia, María J. Pajares, Francisco Hermida‐Prado et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 69 citations · Full text

Medicine, Molecular Biology, Oncology +17

Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets

Saúl Álvarez–Teijeiro, Cristina García–Inclán, M. Ángeles Villaronga et al. · Cancers · 2018 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +17

Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin

Javier Menéndez-Menéndez, Francisco Hermida‐Prado, Rocío Granda‐Díaz et al. · Cancers · 2019 · 47 citations · Full text

Medicine, Oncology, Pharmacology +15